- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00295516
Doppler or Amniocentesis to Predict Fetal Anemia
Minimally Invasive Management of Rh Alloimmunization: Can Amniotic Fluid DeltaOD450 Measurements Be Replaced by Doppler Studies?
In pregnancies complicated by Rhesus disease, the mother has developed antibodies which cross the placenta and can cause anemia and death of the fetus. When the anemia is detected on time, the fetus can be saved by giving it blood transfusions during the pregnancy.
The standard test to predict whether the fetus needs a blood transfusion is examination of the amniotic fluid. To obtain this fluid a needle has to be inserted in the womb, which has a risk of preterm delivery, infection, and making the disease worse. This is called amniocentesis.
A new safe test, using Doppler ultrasound, has been developed to possibly replace the amniocentesis.
The aim of this study is to compare the new Doppler test with the standard amniocentesis. If the Doppler test is at least as good, this safe test may replace the amniocentesis in the management of pregnancies with Rhesus disease.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In pregnancies complicated by red cell alloimmunization, the fetus may suffer from chronic progressive hemolytic anemia. Severe fetal anemia leading to hydrops and fetal demise can occur as early as 17 weeks' gestation, while in other pregnancies the only manifestation of the disease is neonatal hyperbilirubinemia. The standard of care in the management of these pregnancies is to select patients at risk of fetal anemia using information about their obstetric history, and serial maternal serum antibody measurements. The selected patients are followed closely, usually in referral centers with a special interest and expertise in managing this now relatively rare disease. Ultrasound evaluation of fetal condition, with emphasis on signs of fetal hydrops, is performed regularly. In addition, serial amniocentesis is done to assess amniotic fluid bilirubin (deltaOD450) values. This spectrophotometric method estimates the level of bilirubin in the amniotic fluid, which correlates with the severity of the hemolytic process.
Although this diagnostic test, introduced by Liley in 1961, has served fetal medicine specialists well for almost 40 years, the invasive nature of the method is considered a serious disadvantage. Furthermore, its reliability has been questioned, especially when used in the second trimester. In the past decade, noninvasive alternative methods to predict the degree of fetal anemia have been developed.
The most promising of these new diagnostic tests is Doppler measurement of fetal blood flow velocities. Fetal blood flow velocity has been shown to correlate linearly with the degree of anemia. Recently, middle cerebral artery (MCA) peak flow velocity measurements have been reported to reliably predict presence or absence of fetal anemia.
The aim of this study is to compare the performance of this new noninvasive diagnostic test with the standard test, amniocentesis for amniotic fluid deltaOD450 values. In an international multicenter setting, a large cohort of consecutive Rh-alloimmunized pregnancies will be studied prospectively. Both diagnostic tests will be performed simultaneously in all patients, and compared with the "gold standard", fetal blood sampling (FBS) to assess the actual hemoglobin concentration.
Study Type
Enrollment
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X5
- Mt. Sinai Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Pregnant women with red cell alloimmunization associated with a risk of fetal anemia (D, E, c or Duffy (Fya )antibodies, alone or in combination with other antibodies)
- Gestational age between 12 and 34 weeks at study entry, viable fetus and accurate dating
- Maternal serum test-result, above the threshold at which the fetus is considered to be at risk of developing hemolytic anemia and thus a potential candidate for invasive testing.
Exclusion Criteria:
- Presence of Kell-antibodies
- Presence of fetal hydrops at first ultrasonographic examination
- Major fetal congenital or chromosomal anomalies
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Sensitivity Middle Cerebral Artery (MCA) peak velocity Doppler measurement and amniotic fluid deltaOD450 measurements, to predict fetal anemia requiring transfusion.
|
Specificity of Middle Cerebral Artery (MCA) peak velocity Doppler measurement and amniotic fluid deltaOD450 measurements, to predict fetal anemia requiring transfusion.
|
Secondary Outcome Measures
Outcome Measure |
---|
Comparison of the sensitivity and specificity of the original, linearly extended Liley chart with the Queenan (1993) chart, by plotting the deltaOD450 results found in our study in both charts.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Dick Oepkes, MD, PhD, Leiden University Medical Centre, The Netherlands
- Principal Investigator: Gareth P Seaward, MB, BCh, MSc, Mt.Sinai Hospital, University of Toronto, Canada
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MSH-REB 01-0266-U
- PSI Grant Number:01-13
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rh Isoimmunization
-
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion...Leiden University Medical CenterUnknownErythroblastosis, Fetal | Erythroblastosis Fetalis, Rh Disease | Erythroblastosis Fetalis Due to RH Antibodies | Erythroblastosis Fetalis Due to IsoimmunizationNetherlands
-
Benha UniversityRecruiting
-
Laboratoire français de Fractionnement et de BiotechnologiesCompleted
-
Fundació Institut de Recerca de l'Hospital de la...UnknownPregnant Women | Rh-Hr Blood-Group SystemSpain
-
Centre Hospitalier Universitaire de BesanconCompleted
-
Guangzhou Blood CenterCompleted
-
Guangzhou Blood CenterCompleted
-
Aga Khan UniversityThe Hospital for Sick Children; Grand Challenges CanadaCompletedRhesus Disease | Anti-D (Rh) Antibodies Affecting Care of MotherPakistan
-
National Research Centre, EgyptCairo UniversityCompletedFetal Anemia as Antepartum Condition (Diagnosis) | Rh Incompatible Blood Transfusion NosEgypt
-
Assistance Publique Hopitaux De MarseilleWithdrawnNeonatal Thrombocytopenia Isoimmunization Maternal-fetalFrance
Clinical Trials on Fetal Middle Cerebral Artery Doppler measurement
-
Cairo UniversityUnknown
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; LMS Polytechnique and M3DISIM, InriaRecruitingIntensive Care Unit SyndromeFrance
-
University Hospital Inselspital, BerneCompleted
-
Columbia UniversityCompletedTwin Twin Transfusion SyndromeUnited States
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMRecruitingGeneral AnesthesiaFrance
-
Kanuni Sultan Suleyman Training and Research HospitalCompleted
-
Imperial College LondonCompletedInfarction, Middle Cerebral Artery | Stroke, AcuteUnited Kingdom
-
Hospital Universitario Central de AsturiasHospitales Universitarios Virgen del RocíoCompletedInfarction, Middle Cerebral Artery | Stroke, AcuteSpain
-
Istanbul UniversityUnknownUltrasonography | Anesthesia | Catheterization | Radial ArteryTurkey
-
Second Affiliated Hospital of Wenzhou Medical UniversityNot yet recruiting